Intrinsiqq
Medinotec Inc. logo

Medinotec Inc.

MDNC
⊜ Compare
ProfitabilityThin marginsGrowthSteady growthCash FlowThin conversionValuationN/A
What stands out

11.25% operating margin is respectable but not wide. ROIC at 17.23%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.

What's changing

Revenue grew 6.8%, steady but not accelerating. Margins contracted 23.8pp, which offsets some of the top-line progress.

What deserves caution

ROIC dropped from 77.07% to 17.23%, capital efficiency is deteriorating. Operating margin contracted 23.8pp YoY, cost discipline may be slipping.

Profitability & Returns

Revenue (TTM)

$10M

▲ +6.8% YoY

Net Income (TTM)

$597K

▼ -63.2% YoY

Op. Margin

6.58%

▼ -23.8pp YoY

ROIC

9.18%

▼ -59.8pp YoY

Cash Flow & Balance Sheet

FCF (TTM)

$374K

▲ +14.8% YoY

Op. Cash Flow (TTM)

$374K

▲ +3.3% YoY

Net Debt

-$2M

Net Cash Position

Cash & Equiv.

$3M

3Y CAGR: +113.5%

Continue Research

SourceComputed from the 10-Q filed 8 Oct 2026, covering the period ending 31 Aug 2026, as reported to the SEC. Data last refreshed 9 Oct 2026. How this is calculated.

Fiscal year ends Feb. Sector medians are approximate S&P 500 benchmarks and update periodically.

Related stocks: Surgical & Medical Instruments & Apparatus

Spot a number that looks wrong?

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.